Evidence map›Paper›PMID 36835174›Full record

ArticleInternational journal of molecular sciences2023

Detection of Breast Cancer-Specific Extracellular Vesicles with Fiber-Optic SPR Biosensor.

Yagmur Yildizhan, Kaat Driessens, Hong Shen Kevin Tsao, Robin Boiy, Debby Thomas, Nick Geukens, An Hendrix, Jeroen Lammertyn, Dragana Spasic

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yagmur YildizhanDepartment of Biosystems, Biosensors Group, Katholieke Universiteit Leuven, 3001 Leuven, Belgium.ORCID 0000-0003-0246-3124
Kaat DriessensDepartment of Biosystems, Biosensors Group, Katholieke Universiteit Leuven, 3001 Leuven, Belgium.
Hong Shen Kevin TsaoDepartment of Biosystems, Biosensors Group, Katholieke Universiteit Leuven, 3001 Leuven, Belgium.
Robin BoiyLaboratory of Experimental Cancer Research, Cancer Research Institute Ghent, Department of Human Structure and Repair, Ghent University, 9000 Ghent, Belgium.
Debby ThomasPharmAbs, The KU Leuven Antibody Center, University of Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-3075-9846
Nick GeukensPharmAbs, The KU Leuven Antibody Center, University of Leuven, 3000 Leuven, Belgium.
An HendrixLaboratory of Experimental Cancer Research, Cancer Research Institute Ghent, Department of Human Structure and Repair, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0002-1883-8309
Jeroen LammertynDepartment of Biosystems, Biosensors Group, Katholieke Universiteit Leuven, 3001 Leuven, Belgium.ORCID 0000-0001-8143-6794
Dragana SpasicDepartment of Biosystems, Biosensors Group, Katholieke Universiteit Leuven, 3001 Leuven, Belgium.ORCID 0000-0001-9882-5091
KU Leuven · BEGhent University · BE

Funding

European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie 764281Kom op tegen Kanker 13050Research Foundation - Flanders FWO SBO/S006319NVlaamse Liga tegen Kanker C8744
6 · The paper itself

Abstract

Extracellular vesicles (EVs) have attracted great attention as potential biomarkers for cancer diagnostics. Although several technologies have been developed for EV detection, many of them are still not applicable to clinical settings as they rely on complex EV isolation processes, while lacking sensitivity, specificity or standardization. To solve this problem, we have developed a sensitive breast cancer-specific EV detection bioassay directly in blood plasma using a fiber-optic surface plasmon resonance (FO-SPR) biosensor, previously calibrated with recombinant EVs. First, we established a sandwich bioassay to detect SK-BR-3 EVs by functionalizing the FO-SPR probes with anti-HER2 antibodies. A calibration curve was built using an anti-HER2/

Indexed as

Biosensing TechniquesBreast NeoplasmsExtracellular VesiclesBiomarkersFemaleHumansSurface Plasmon ResonanceBiomarkersbiosensorsbreast cancerEpCAMextracellular vesiclesfiber-optic surface plasmon resonanceHER2

Identifiers

PMID36835174
PMCPMC9966403
OpenAlexW4320731205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.